NO20016344L - Nye polypeptider og deres DNA - Google Patents

Nye polypeptider og deres DNA

Info

Publication number
NO20016344L
NO20016344L NO20016344A NO20016344A NO20016344L NO 20016344 L NO20016344 L NO 20016344L NO 20016344 A NO20016344 A NO 20016344A NO 20016344 A NO20016344 A NO 20016344A NO 20016344 L NO20016344 L NO 20016344L
Authority
NO
Norway
Prior art keywords
polypeptides
salts
compounds
present
dna
Prior art date
Application number
NO20016344A
Other languages
English (en)
Other versions
NO20016344D0 (no
Inventor
Yasuaki Itoh
Kazunori Nishi
Kazuhiro Ogi
Shoichi Ohkubo
Shinichi Mogi
Yuko Noguchi
Koji Yoshimura
Hideyuki Tanaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20016344D0 publication Critical patent/NO20016344D0/no
Publication of NO20016344L publication Critical patent/NO20016344L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016344A 1999-06-30 2001-12-21 Nye polypeptider og deres DNA NO20016344L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18671899 1999-06-30
PCT/JP2000/004278 WO2001002564A1 (fr) 1999-06-30 2000-06-29 Nouveau polypeptide et adn de ce polypeptide

Publications (2)

Publication Number Publication Date
NO20016344D0 NO20016344D0 (no) 2001-12-21
NO20016344L true NO20016344L (no) 2002-02-19

Family

ID=16193433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016344A NO20016344L (no) 1999-06-30 2001-12-21 Nye polypeptider og deres DNA

Country Status (12)

Country Link
US (1) US6797483B1 (no)
EP (1) EP1191099B1 (no)
KR (1) KR20020026465A (no)
CN (1) CN1359421A (no)
AT (1) ATE445013T1 (no)
AU (1) AU5705600A (no)
CA (1) CA2377791A1 (no)
DE (1) DE60043106D1 (no)
HU (1) HUP0201660A2 (no)
NO (1) NO20016344L (no)
PL (1) PL353065A1 (no)
WO (1) WO2001002564A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
WO2001055332A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
AU2003250547A1 (en) * 2002-08-05 2004-02-23 Asahi Kasei Kabushiki Kaisha Cartilage differentiation inhibiting gene
AU2003259696A1 (en) * 2002-08-08 2004-02-25 Nuvelo, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
MXPA05010635A (es) 2003-04-02 2005-12-12 Ares Trading Sa Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico.
ES2414705T3 (es) 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
US10660852B2 (en) 2015-09-18 2020-05-26 Bionet Pharma Gmbh Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710248B1 (de) 1993-07-20 1999-09-29 Roche Diagnostics GmbH Melanom-inhibierendes protein
WO1998031799A2 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
JP2003525568A (ja) * 1997-12-20 2003-09-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 分泌蛋白およびそれらをコードするポリヌクレオチド
AU2225401A (en) 1999-12-27 2001-07-09 Takeda Chemical Industries Ltd. Novel protein and dna thereof
WO2001055332A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
JP6623690B2 (ja) 2015-10-30 2019-12-25 味の素株式会社 グルタミン酸系ｌ−アミノ酸の製造法

Also Published As

Publication number Publication date
AU5705600A (en) 2001-01-22
DE60043106D1 (de) 2009-11-19
EP1191099B1 (en) 2009-10-07
WO2001002564A1 (fr) 2001-01-11
PL353065A1 (en) 2003-10-06
EP1191099A1 (en) 2002-03-27
US6797483B1 (en) 2004-09-28
CA2377791A1 (en) 2001-01-11
HUP0201660A2 (en) 2002-08-28
ATE445013T1 (de) 2009-10-15
KR20020026465A (ko) 2002-04-10
CN1359421A (zh) 2002-07-17
NO20016344D0 (no) 2001-12-21
EP1191099A4 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
DE60207652D1 (de) Durch Säuregruppen disubstitierte Heteroaryl-Derivate und ihre Verwendung als Matrix Metalloproteinas Inhibitoren
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
SE9903544D0 (sv) Novel compounds
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE60314495D1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
NO20021542L (no) Nye <alfa>-aminosyresulfonylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
BR0210358A (pt) Inibidores da protease de hiv, composições contendo os mesmos, seus usos farmacêuticos e materiais para sua sìntese
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
NO20022285L (no) Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
DK15589D0 (da) Kemiske forbindelser
DE60307701D1 (de) Mannose-Bindungsprotein enthaltende pharmazeutische Zusammensetzungen
FR2848413B1 (fr) Plaque d'osteosynthese pour l'osteosynthese de petits os voisins les uns des autres
SE0400043D0 (sv) New compounds
DE60300021D1 (de) (S)-4-Amino-5-Chloro-2-Methoxy-N-[1-[1-(2-Tetrahydrofuryl-Carbonyl)-4-Piperidinylmethyl]-4-Piperidinyl]benzamid zur Behandlung von Magen-Darmbewegungskrankheiten
BR0016742A (pt) Compostos e composições antipicorna virais, suas aplicações farmacêuticas, e materiais para sua sìntese
SE9804212D0 (sv) Compounds
NO20016344D0 (no) Nye polypeptider og deres DNA
BR0211635A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer
DK383388D0 (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
BR9811821A (pt) 2-acilaminopropanaminas como antagonistas de receptores de taquicinina
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application